Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines

Breast Cancer Research and Treatment

Volumn 126, Issue 1, 2011, Pages 55-62

  Millon, Stacy R ^a   Ostrander, Julie H ^b   Brown, J Quincy ^a   Raheja, Anita ^a   Seewaldt, Victoria L ^b   Ramanujam, Nirmala ^a  

^a Duke University   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 NBDG; Breast cancer cell lines; Confocal microscopy; GLUT 1; Tamoxifen

Indexed keywords

2 [N (7 NITROBENZ 2 OXA 1,3 DIAZOL 4 YL)AMINO] 2 DEOXYGLUCOSE; ALPHA CYANO 4 HYDROXYCINNAMIC ACID; ESTROGEN RECEPTOR; GLUCOSE DERIVATIVE; GLUCOSE TRANSPORTER 1; HEXOKINASE 1; LONIDAMINE; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL LABELING; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TUMOR LEVEL; DRUG UPTAKE; EPITHELIUM CELL; FLUORESCENCE ANALYSIS; GLYCOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

4-CHLORO-7-NITROBENZOFURAZAN; ANTINEOPLASTIC AGENTS, HORMONAL; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CELLS, CULTURED; DEOXYGLUCOSE; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HEXOKINASE; HUMANS; PHOSPHORYLATION; RECEPTORS, ESTROGEN; TAMOXIFEN; TREATMENT OUTCOME;

EID: 79151480961     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0884-1     Document Type: Article

References (28)

1. HJ Biersack H Bender H Palmedo 2004 FDG-PET in monitoring therapy of breast cancer Eur J Nucl Med Mol Imaging 31 Suppl 1 S112 S117 10.1007/s00259-004-1533-x 15112111 (Pubitemid 38833040)
2. N Nitin AL Carlson T Muldoon AK El-Naggar A Gillenwater, et al. 2009 Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose Int J Cancer 124 2634 2642 1:CAS:528:DC%2BD1MXltlegurw%3D 10.1002/ijc.24222 19173294
3. RG O'Neil L Wu N Mullani 2005 Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells Mol Imaging Biol 7 388 392 10.1007/s11307-005-0011-6 16284704 (Pubitemid 44193403)
4. L Livshits A Caduff MS Talary HU Lutz Y Hayashi, et al. 2009 The role of GLUT1 in the sugar-induced dielectric response of human erythrocytes J Phys Chem B 113 2212 2220 1:CAS:528:DC%2BD1MXpslylsA%3D%3D 10.1021/jp808721w 19166280
5. DD Meira MM Marinho-Carvalho CA Teixeira VF Veiga AT Da Poian, et al. 2005 Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes Mol Genet Metab 84 354 362 1:CAS:528:DC%2BD2MXisFKjtLg%3D 10.1016/j.ymgme.2004.11.012 15781197 (Pubitemid 40386883)
6. Q He RZ Xu P Shkarin G Pizzorno CH Lee-French, et al. 2003 Magnetic resonance spectroscopic imaging of tumor metabolic markers for cancer diagnosis, metabolic phenotyping, and characterization of tumor microenvironment Dis Markers 19 69 94 1:CAS:528:DC%2BD3sXhtFShtb4%3D 15096706 (Pubitemid 38530354)
7. E Furman E Rushkin R Margalit P Bendel H Degani 1992 Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging J Steroid Biochem Mol Biol 43 189 195 1:CAS:528:DyaK38XmtVCksLY%3D 10.1016/0960-0760(92)90207-Y 1525059
8. P Mestres A Morguet W Schmidt A Kob E Thedinga 2006 A new method to assess drug sensitivity on breast tumor acute slices preparation Ann N Y Acad Sci 1091 460 469 1:CAS:528:DC%2BD2sXjsFSgsL8%3D 10.1196/annals.1378.088 17341636 (Pubitemid 47092258)
9. VK Ramanujan BA Herman 2008 Nonlinear scaling analysis of glucose metabolism in normal and cancer cells J Biomed Opt 13 031219 10.1117/1.2928154 18601543
10. K Yoshioka M Saito KB Oh Y Nemoto H Matsuoka, et al. 1996 Intracellular fate of 2-NBDG, a fluorescent probe for glucose uptake activity, in Escherichia coli cells Biosci Biotechnol Biochem 60 1899 1901 1:CAS:528:DyaK28XntlKnurg%3D 10.1271/bbb.60.1899 8987871 (Pubitemid 27054357)
11. R Bos JJ van Der Hoeven E van Der Wall P van Der Groep PJ van Diest, et al. 2002 Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography J Clin Oncol 20 379 387 1:CAS:528:DC%2BD38XovVKisQ%3D%3D 10.1200/JCO.20.2.379 11786564 (Pubitemid 34072519)
12. RA Sheth L Josephson U Mahmood 2009 Evaluation and clinically relevant applications of a fluorescent imaging analog to fluorodeoxyglucose positron emission tomography J Biomed Opt 14 064014 10.1117/1.3259364 20059252
13. J Levi Z Cheng O Gheysens M Patel CT Chan, et al. 2007 Fluorescent fructose derivatives for imaging breast cancer cells Bioconjug Chem 18 628 634 1:CAS:528:DC%2BD2sXksVSmt7s%3D 10.1021/bc060184s 17444608 (Pubitemid 47010780)
14. EC Dietze MM Troch GR Bean JB Heffner ML Bowie, et al. 2004 Tamoxifen and tamoxifen ethyl bromide induce apoptosis in acutely damaged mammary epithelial cells through modulation of AKT activity Oncogene 23 3851 3862 1:CAS:528:DC%2BD2cXjs1yltro%3D 10.1038/sj.onc.1207480 14990993 (Pubitemid 38725698)
15. SR Millon JH Ostrander S Yazdanfar JQ Brown JE Bender, et al. 2010 Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes J Biomed Opt 15 018002 10.1117/1.3302811 20210488
16. JS Erlichman A Hewitt TL Damon M Hart J Kurascz, et al. 2008 Inhibition of monocarboxylate transporter 2 in the retrotrapezoid nucleus in rats: a test of the astrocyte-neuron lactate-shuttle hypothesis J Neurosci 28 4888 4896 1:CAS:528:DC%2BD1cXlvFertr8%3D 10.1523/JNEUROSCI.5430-07.2008 18463242
17. A Floridi MG Paggi S D'Atri C De Martino ML Marcante, et al. 1981 Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells Cancer Res 41 4661 4666 1:CAS:528:DyaL38Xktl0%3D 7306982 (Pubitemid 12201388)
18. R Pincheira Q Chen JT Zhang 2001 Identification of a 170-kDa protein over-expressed in lung cancers Br J Cancer 84 1520 1527 1:CAS:528: DC%2BD3MXltFaqsr4%3D 10.1054/bjoc.2001.1828 11384103 (Pubitemid 32579345)
19. D Rivenzon-Segal S Boldin-Adamsky D Seger R Seger H Degani 2003 Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer Int J Cancer 107 177 182 1:CAS:528:DC%2BD3sXnsFahsbY%3D 10.1002/ijc.11387 12949791 (Pubitemid 37152894)
20. H Pelicano DS Martin RH Xu P Huang 2006 Glycolysis inhibition for anticancer treatment Oncogene 25 4633 4646 1:CAS:528:DC%2BD28Xnsl2hs7Y%3D 10.1038/sj.onc.1209597 16892078 (Pubitemid 44187614)
21. RS Brown TM Goodman KR Zasadny JK Greenson RL Wahl 2002 Expression of hexokinase II and Glut-1 in untreated human breast cancer Nucl Med Biol 29 443 453 1:CAS:528:DC%2BD38XjvVWjur0%3D 10.1016/S0969-8051(02)00288-3 12031879 (Pubitemid 34597116)
22. S Di Cosimo G Ferretti P Papaldo P Carlini A Fabi, et al. 2003 Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors Drugs Today (Barc) 39 157 174 1:CAS:528:DC%2BD3sXktF2gsLs%3D 10.1358/dot.2003.39.3.799451 (Pubitemid 36514356)
23. P Sonveaux F Vegran T Schroeder MC Wergin J Verrax, et al. 2008 Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice J Clin Invest 118 3930 3942 1:CAS:528:DC%2BD1cXhsVKgu7rI 19033663
24. D Rivenzon-Segal R Margalit H Degani 2002 Glycolysis as a metabolic marker in orthotopic breast cancer, monitored by in vivo (13)C MRS Am J Physiol Endocrinol Metab 283 E623 E630 1:CAS:528:DC%2BD38XotV2rur0%3D 12217878
25. SS Perumal P Shanthi P Sachdanandam 2005 Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer Cancer Chemother Pharmacol 56 105 114 1:CAS:528:DC%2BD2MXjvFKrsb4%3D 10.1007/s00280-004-0943-6 15726365 (Pubitemid 41201763)
26. A Monazzam R Josephsson C Blomqvist J Carlsson B Langstrom, et al. 2007 Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer Breast Cancer Res 9 R45 10.1186/bcr1747 17659092 (Pubitemid 350187476)
27. A Monazzam P Razifar M Simonsson F Qvarnstrom R Josephsson, et al. 2006 Multicellular tumour spheroid as a model for evaluation of [18F]FDG as biomarker for breast cancer treatment monitoring Cancer Cell Int 6 6 10.1186/1475-2867-6- 6 16556298
28. AF Chambers 2009 MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 69 5292 5293 1:CAS:528:DC%2BD1MXnvFWqurg%3D 10.1158/0008-5472.CAN-09-1528 19549886